Morgan Stanley Vitality Portfolio A (MSVEX)

Fund Assets	2.29M
Expense Ratio	1.30%
Min. Investment	$1,000
Turnover	n/a
Dividend (ttm)	0.14
Dividend Yield	2.12%
Dividend Growth	n/a
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jun 9, 2026

Previous Close	6.48
YTD Return	-0.18%
1-Year Return	23.88%
5-Year Return	n/a
52-Week Low	5.15
52-Week High	6.83
Beta (5Y)	n/a
Holdings	33
Inception Date	Dec 31, 2021

About MSVEX

Morgan Stanley Institutional Fund, Inc. Vitality Portfolio Class A is an actively managed mutual fund primarily focused on the U.S. healthcare sector. The portfolio invests mainly in equity securities of companies engaged in pharmaceuticals, biotechnology, healthcare equipment, and related healthcare industries. Managed by Counterpoint Global within Morgan Stanley Investment Management, the fund seeks to identify high-quality companies with sustainable competitive advantages, using a concentrated and conviction-weighted investment approach. This results in a portfolio where the top ten holdings can represent a significant portion of assets, reflecting strong beliefs in select healthcare innovators and market leaders. The fund's strategy emphasizes stock selection over broad sector allocation, aiming to differentiate from health care benchmarks such as the Russell 3000 Health Care Index. Its role in the market is to provide investors with targeted exposure to healthcare equities, seeking growth opportunities within one of the most dynamic and essential sectors of the economy. The fund is structured with a front-end load and charges an expense ratio that is above the category average, which investors should weigh alongside its active, high-conviction style.

• Category: Health
• Performance Rating: Below Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: MSVEX
• Share Class: Class A
• Index: Russell 3000 TR

Performance

MSVEX had a total return of 23.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.42%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MSVOX	Class R6	0.90%
MSVDX	Class I	0.95%
MSVMX	Class C	2.05%

Top 10 Holdings

49.09% of assets

Name	Symbol	Weight
argenx SE	ARGX	8.03%
Eli Lilly and Company	LLY	7.79%
Ascendis Pharma A/S	ASND	5.48%
Nektar Therapeutics	NKTR	4.75%
Thermo Fisher Scientific Inc.	TMO	4.28%
Align Technology, Inc.	ALGN	4.18%
Enliven Therapeutics, Inc.	ELVN	3.90%
10x Genomics, Inc.	TXG	3.77%
NewAmsterdam Pharma Company N.V.	NAMS	3.57%
Structure Therapeutics Inc.	GPCR	3.36%

Dividend History

Ex-Dividend	Amount	Pay Date
Jun 9, 2026	$0.05761	Jun 9, 2026
Dec 11, 2025	$0.07987	Dec 11, 2025

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 28, 2026

Data Sources Report a data error